Mechanisms associated with IL-6-induced up-regulation of Jak3 and its role in monocytic differentiation

Blood

Volumn 103, Issue 11, 2004, Pages 4093-4101

  Mangan, James K ^a   Rane, Sushil G ^a   Kang, Anthony D ^a   Amanullah, Arshad ^a   Wong, Brian C ^a   Reddy, E Premkumar ^a  

^a TEMPLE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; ENZYME INHIBITOR; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 3; INTERLEUKIN 6; JANUS KINASE; JANUS KINASE 3; STAT PROTEIN; STAT3 PROTEIN; STEM CELL FACTOR; TRANSCRIPTION FACTOR SP1; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; BINDING SITE; BONE MARROW CELL; CELL DIFFERENTIATION; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME REGULATION; GEL MOBILITY SHIFT ASSAY; GENE OVEREXPRESSION; MACROPHAGE; MONOCYTE; MOUSE; MUTAGENESIS; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN PROTEIN INTERACTION; T LYMPHOCYTE ACTIVATION;

EID: 2542480822     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood-2003-06-2165     Document Type: Article

References (65)

1. Lotem J, Sachs L. Cytokine control of developmental programs in normal hematopoeisis and leukemia. Oncogene. 2002;21:3284-3294.
2. Rane SG, Reddy EP. JAKs, STATs, and Src kinases in hematopoiesis. Oncogene. 2002;21:3334-3358.
3. Rodig SJ, Meraz MA, White JM, et al. Disruption of the Jak1 gene demonstrates obligatory and nonredundant roles of the Jaks in cytokine-induced biologic responses. Cell. 1998;93:373-383.
4. Park SY, Saijo K, Takahashi T, et al. Developmental defects of lymphoid cells in JAK3 kinase-deficient mice. Immunity. 1995;3:771-782.
5. Thomis DC, Gurniak CB, Tivol E, Sharpe AH, Berg LJ. Defects in B lymphocyte maturation and T lymphocyte activation in mice lacking JAK3. Science. 1995;270:794-797.
6. Nosaka T, van Deursen JM, Tripp RA, et al. Defective lymphoid development in mice lacking JAK3. Science. 1995;270:800-802.
7. Parganas E, Wang D, Stravopodis D, et al. Jak2 is essential for signaling through a variety of cytokine receptors. Cell. 1998;93:385-395.
8. Rane SG, Mangan JK, Amanullah A, et al. Activation of the Jak3 pathway is associated with granulocytic differentiation of myeloid precursor cells. Blood. 2002;100:2753-2762.
9. Witthuhn BA, Silvennoinen O, Miura O, et al. Involvement of the Jak-3 Janus kinase in signaling by interleukins 2 and 4 in lymphoid and myeloid cells. Nature. 1994;370:153-157.
10. Johnston JA, Kawamura M, Kirken RA, et al. Phosphorylation and activation of the Jak-3 Janus kinase in response to interleukin-2. Nature. 1994;370:151-153.
11. Musso T, Johnston JA, Linnekin D, et al. Regulation of JAK3 expression in human monocytes: phosphorylation in response to interleukins 2, 4, and 7. J Exp Med. 1995;181:1425-1431.
12. Malabarba MG, Kirken RA, Rui H, et al. Activation of JAK3, but not JAK1, is critical to interleukin-4 (IL4) stimulated proliferation and requires a membrane-proximal region of IL4 receptor alpha. J Biol Chem. 1995;270:9630-9637.
13. Rolling C, Treton D, Beckmann P, Galanaud P, Richard Y. JAK3 associates with the human interleukin-4 receptor and is tyrosine phosphorylated following receptor triggering. Oncogene. 1995;10:1757-1761.
14. Aringer M, Hofmann, SR, Frucht DM, et al. Characterization and analysis of the proximal Janus Kinase 3 promoter. J Immunol. 2003;170:6057-6064.
15. Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem. 1987;162:156-159.
16. Zaret KS, Liu J, DiPersio CM. Site directed mutagenesis reveals a liver transcription factor essential for the albumin transcriptional enhancer. Proc Natl Acad Sci U S A. 1990;87:5469-5473.
17. Khanna-Gupta A, Zibello T, Simkevich C, Rosmarin AG, Berliner N. Sp1 and C/EBP are necessary to activate the lactoferrin gene promoter during myeloid differentiation. Blood. 2000;95:3734-3741.
18. Kumar A, Reddy EP. Genomic organization and characterization of the promoter region of the murine GSTM2 gene. Gene. 2001;270:221-229.
19. Bromberg JF, Wrzeszczynska MH, Devgan G, et al. Stat3 as an oncogene. Cell. 1999;98:295-303.
20. Sudbeck EA, Liu XP, Narla RK, et al. Structure-based design of specific inhibitors of Janus kinase 3 as apoptosis-inducing antileukemic agents. Clin Cancer Res. 1999;5:1569-1582.
21. Saemann MD, Zeyda M, Diakos C, et al. Suppression of early T-cell-receptor-triggered cellular activation by the Janus kinase 3 inhibitor WHI-P-154. Transplantation. 2003;75:1864-1872.
22. Amin HM, Medeiros LJ, Ma Y, et al. Inhibition of JAK3 induces apoptosis and decreases anaplastic lymphoma kinase activity in anaplastic large cell lymphoma. Oncogene. 2003;22:5399-5407.
23. Garriga J, Limon A, Mayol X, et al. Differential regulation of the retinoblastoma family of proteins during cell proliferation and differentiation. Biochem J. 1998;333:645-654.
24. Patel G, Kreider B, Rovera G, Reddy EP. v-myb blocks granulocyte-colony-stimulating factor-induced myeloid cell differentiation but not proliferation. Mol Cell Biol. 1993;13:2269-2276.
25. Rovera G, Valtieri M, Mavilio F, Reddy EP. Effect of Abelson murine leukemia virus on granulocytic differentiation and interleukin-3 dependence of a murine progenitor cell line. Oncogene. 1987;1:29-35.
26. Valtieri M, Tweardy D, Caracciolo D, et al. Cytokine-dependent granulocytic differentiation: regulation of proliferative and differentiative responses in a murine progenitor cell line. J Immunol. 1987;138:3829-3835.
27. Lord KA, Hoffman-Liebermann B, Liebermann DA. Nucleotide sequence and expression of a cDNA encoding MyD88, a novel myeloid differentiation primary response gene induced by IL-6. Oncogene. 1990;5:1095-1097.
28. Sjin RM, Krishnaraju K, Hoffman B, Liebermann DA. Transcriptional regulation of myeloid difierentiation primary response (MyD) genes during myeloid differentiation is mediated by nuclear factor Y. Blood. 2002;100:80-88.
29. Koike K, NakahataT, Takagi M, et al. Synergism of BSF-2/interleukin 6 and interleukin 3 on development of multipotential hematopoietic progenitors in serum-free culture. J Exp Med. 1988;168:879-890.
30. Miller CL, Rebel VI, Lemieux ME, Helgason CD, Lansdorp PM, Eaves CJ. Studies of W mutant mice provide evidence for alternative mechanisms capable of activating hematopoietic cells. Exp Hematol. 1996;24:185-194.
31. Gurniak CB, Berg LJ. Murine JAK3 is preferentially expressed in hematopoietic tissues and lymphocyte precursor cells. Blood. 1996;87:3151-3160.
32. Horvath CM, Wen Z, Darnell JE Jr. A STAT protein domain that determines DNA sequence recognition suggests a novel DNA-binding domain. Genes Dev. 1995;9:984-994.
33. Xu X, Sun YL, Hoey T. Cooperative DNA binding and sequence-selective recognition conferred by the STAT amino-terminal domain. Science. 1996;273:794-797.
34. Sjin RM, Lord KA, Abdollahi A, Hoffman B, Liebermann DA. Interleukin-6 and leukemia inhibitory factor induction of JunB is regulated by distinct cell type-specific cis-acting elements. J Biol Chem. 1999;274:28697-28707.
35. Minami M, Inoue M, Wei S, et al. STAT3 activation is a critical step in 9p130-mediated terminal differentiation and growth arrest of a myeloid cell line. Proc Natl Acad Sci U S A. 1996;93:3963-3966.
36. Nakajima K, Yamanaka Y, Nakae K, et al. A central role for Stat3 in IL-6-induced regulation of growth and differentiation in M1 leukemia cells. EMBO J. 1996;15:3651-3658.
37. Saijo K, Park SY, Ishida Y, Arase H, Saito T. Crucial role of Jak3 in negative selection of self-reactive T cells. J Exp Med. 1997;185:351-356.
38. Russell SM, Tayebi N, Nakajima H, et al. Mutation of Jak3 in a patient with SCID: essential role of Jak3 in lymphoid development. Science. 1995;270:797-800.
39. Macchi P, Villa A, Giliani S, et al. Mutations of Jak-3 gene in patients with autosomal severe combined immunodeficiency (SCID). Nature. 1995;377:65-68.
40. Candotti F, Oakes SA, Johnston JA, et al. Structural and functional basis for JAK3-deficient severe combined immunodeficiency. Blood. 1997;90:3996-4003.
41. Leonard WJ, O'Shea JJ. JAKS AND STATS: biological implications. Ann Rev Immunol. 1998;16:293-322.
42. Grossman WJ, Verbsky JW, Yang L, et al. Dysregulated myelopoiesis in mice lacking Jak3. Blood. 1999;94:932-939.
43. Saemann MD, Diakos C, Kelemen P, et al. Prevention of CD40-triggered dendritic cell maturation and induction of T-cell hyporeactivity by targeting of Janus kinase 3. Am J Transplant. 2003;3:1341-1349.
44. Revy P, Hivroz C, Andreu G, et al. Activation of the Janus kinase 3-STAT5a pathway after CD40 triggering of human monocytes but not of resting B cells. J Immunol. 1999;163:787-793.
45. Lieschke GJ, Grail D, Hodgson G, et al. Mice lacking granulocyte-colony-stimulating factor have chronic neutropenia, granulocyte and macrophage progenitor cell deficiency, and impaired neutrophil mobilization. Blood. 1994;84:1737-1746.
46. Yoshida K, Taga T, Saito M, et al. Targeted disruption of gp130, a common signal transducer for the interleukin 6 family of cytokines, leads to myocardial and hematological disorders. Proc Natl Acad Sci U S A. 1996;93:407-411.
47. Kopf M, Baumann H, Freer G, et al. Impaired immune and acute-phase responses in interleukin-6-deficient mice. Nature. 1994;368:339-342.
48. Rane SG, Reddy EP. JAK3: a novel JAK kinase associated with terminal differentiation of hematopoietic cells. Oncogene. 1994;9:2415-2423.
49. Saffer JD, Jackson SP, Annarella MB. Developmental expression of Sp1 in the mouse. Mol Cell Biol. 1991;11:2189-2199.
50. Chen HM, Pahl HL, Scheibe RJ, Zhang DE, Tenen DG. The Sp1 transcription factor binds the CD11b promoter specifically in myeloid cells in vivo and is essential for myeloid-specific promoter activity. J Biol Chem. 1993;268:8230-8239.
51. Noti JD, Reinemann BC, Petrus MN. Sp1 binds two sites in the CD11c promoter in vivo specifically in myeloid cells and cooperates with AP1 to activate transcription. Mol Cell Biol. 1996;16:2940-2950.
52. Zhang DE, Hetherington CJ, Tan S, et al. Sp1 is a critical factor for the monocytic specific expression of human CD14. J Biol Chem. 1994;269:11425-11434.
53. Rosmarin AG, Luo M, Caprio DG, Shang J, Simkevich CP. Sp1 cooperates with the ets transcription factor, GABP, to activate the CD18 (β2 leukocyte integrin) promoter. J Biol Chem. 1998;273:13097-13103.
54. Heydemann A, Juang G, Hennessy K, Parmacek MS, Simon MC. The myeloid-cell-specific c-fos promoter is regulated by Sp1, PU. 1, and a novel transcription factor. Mol Cell Biol. 1996;16:1676-1686.
55. Piedrafita FJ, Molander RB, Vansant G, Orlova EA, Pfahl M, Reynolds WF. An Alu element in the myeloperoxidase promoter contains a composite SP1-thyroid hormone-retinoic acid response element. J Biol Chem. 1996;271:14412-14420.
56. Nuchprayoon I, Shang J, Simkevich CP, Luo M, Rosmarin AG, Friedman AD. An enhancer located between the neutrophil elastase and proteinase 3 promoters is activated by Sp1 and an Ets factor. J Biol Chem. 1999;274:1085-1091.
57. Kao WY, Briggs JA, Kinney MC, Jensen RA, Briggs RC. Structure and function analysis of the human myeloid cell nuclear differentiation antigen promoter: evidence for the role of Sp1 and not of c-Myb or PU.1 in myelomonocytic lineage-specific expression. J Cell Biochem. 1997;65:231-244.
58. Hauses M, Tönjes RR, Grez M. The transcription factor Spl regulates the myeloid-specific expression of the human hematopoietic cell kinase (HCK) gene through binding to two adjacent GC boxes within the HCK promoter-proximal region. J Biol Chem. 1998;273:31844-31852.
59. Look DC, Pelletier MR, Tidwell RM, Roswit WT, Holtzman MJ. Stat1 depends on transcriptional synergy with Sp1. J Biol Chem. 1995;270:30264-30267.
60. Martino A, Holmes JH IV, Lord JD, Moon JJ, Nelson BH. Stat5 and Sp1 regulate transcription of the cyclin D2 gene in response to IL-2. J Immunol. 2001;166:1723-1729.
61. Cantwell CA, Sterneck E, Johnson PF. Interleukin-6-specific activation of the C/EBPδ gene in hepatocytes is mediated by Stat3 and Sp1. Mol Cell Biol. 1998;18:2108-2117.
62. Lutticken C, Wegenka UM, Yuan J, et al. Association of transcription factor APRF and protein kinase Jak1 with the interleukin-6 signal transducer gp130. Science. 1994;263:89-92.
63. Matsuda T, Yamanaka Y, Hirano T. Interleukin-6-induced tyrosine phosphorylation of multiple proteins in murine hematopoietic lineage cells. Biochem Biophys Res Commun. 1994;200:821-828.
64. Stahl N, Boulton TG, Farruggella T, et al. Association and activation of Jak-Tyk kinases by CNTF-LIF-OSM-IL-6 beta receptor components. Science. 1994;263:92-95.
65. Muthusamy N, Barton K, Leiden JM. Defective activation and survival of T cells lacking the Ets-1 transcription factor. Nature. 1995;377:639-642.